“…Compared our results with the previous literature (Wang et al, ), the t 1/2 of demethylbellidifolin in rats after a single dose of pure substance was shorter than that of G. acuta extract (demethylbellidifolin, t 1/2 = 24.9 h), suggesting that other components in the extract may influence the pharmacokinetic behaviors of demethylbellidifolin. The absolute oral bioavailability of demethylbellidifolin in rats was low with a value of 3.6%, which was comparable with those of other xanthones, such as α ‐mangostin, neomangiferin, gambogic acid and sibiricaxanthone F (Li et al, ; Yang et al, ; Yang, Liu, Shang, Qin, & Xia, ; Zheng, Ou, Zhang, Li, & Li, ). Owing to the poor bioavailability of demethylbellidifolin, more attention should be paid to the in vivo metabolites of demethylbellidifolin that might exist in plasma in the further studies.…”